# China NMPA Drug Inspection - Henan Kanghua Pharmaceutical Co., Ltd. - Schisandra chinensis

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/henan-kanghua-pharmaceutical-co-ltd/45a019e2-0e6b-46d9-9492-9a75e55f4c66/
Source feed: China

> China NMPA drug inspection for Henan Kanghua Pharmaceutical Co., Ltd. published January 12, 2017. Drug: Schisandra chinensis. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement No. 5 of 2017 from the State Administration for Market Regulation on the Results of Special Sampling Inspections of Chinese Medicinal Herbs and Prepared Slices
- Company Name: Henan Kanghua Pharmaceutical Co., Ltd.
- Publication Date: 2017-01-12
- Drug Name: Schisandra chinensis
- Inspection Finding: Carmine or Acid Red 73 was detected, indicating a staining problem.
- Action Taken: We have taken timely and lawful measures to control the products, including sealing and seizing, suspending production and sales, and requiring companies to voluntarily recall their products. We have also filed cases against the relevant companies and units for investigation and punishment.

Company: https://www.globalkeysolutions.net/companies/henan-kanghua-pharmaceutical-co-ltd/65fe6acd-7740-40b0-854c-ef43a01a3d24/